Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Johnson & Johnson announced a quarterly dividend

10/20/23 JNJ

Board of Directors of Positive Technologies Group recommended that dividends be paid for 9 months 2023

10/19/23 POSI

Rostelecom creates national cybersecurity centers

10/19/23 RTKM

VSMPO-AVISMA reported for 9 months of 2023 by RAS

10/19/23 VSMO

ALLOW INERTA is being tested in China

10/19/23 RUAL

PMI reported for 9 months of 2023

10/19/23 PM

American Airlines reported for 9 months of 2023

10/19/23 AAL

AT&T reported for 9 months of 2023

10/19/23 T

VK shares will start trading on October 20

10/19/23 VKCO

Alpha test of the Nau Engine game engine will start on November 1

10/19/23 VKCO